Eldred Kary (CIK 0001543425)

Latest company ownership

GALT - GALECTIN THERAPEUTICS INC

Role: Director

Shares held

4,425

Last filed at

Jul 23, 2024

Confidence Score

92.8

2025Q4

Confidence Score History

2018Q3 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Dec 23, 2025	Dec 23, 2025	GALECTIN THERAPEUTICS INC	Director	Buy	77.5	+700	1.01%	✗	$2.6K
Dec 23, 2025	Dec 23, 2025	GALECTIN THERAPEUTICS INC	Director	Buy	77.5	+700	1.01%	✗	$2.6K
Jul 21, 2025	Jul 22, 2025	GALECTIN THERAPEUTICS INC	Director	Buy	77.5	+1,000	1.47%	✗	$2.9K
Dec 24, 2024	Dec 26, 2024	GALECTIN THERAPEUTICS INC	Director	Buy	91.3	+13,469	24.65%	✗	$11K
Oct 23, 2024	Oct 23, 2024	GALECTIN THERAPEUTICS INC	Director	Buy	67.5	+500	0.92%	✗	$1.3K
Jul 22, 2024	Jul 23, 2024	GALECTIN THERAPEUTICS INC	Director	Buy	67.5	+400	0.74%	✗	$956
Jan 16, 2024	Jul 23, 2024	GALECTIN THERAPEUTICS INC	Director	Buy	67.5	+400	0.74%	✗	$956
Jan 16, 2024	Jan 16, 2024	GALECTIN THERAPEUTICS INC	Director	Buy	67.5	+500	0.94%	✗	$892.9
Jul 19, 2023	Jul 20, 2023	GALECTIN THERAPEUTICS INC	Director	Buy	82.5	+1,598	3.09%	✗	$2.9K
Feb 21, 2023	Feb 21, 2023	GALECTIN THERAPEUTICS INC	Director	Buy	77.5	+1,000	1.97%	✗	$1.6K
Jan 25, 2023	Jan 26, 2023	GALECTIN THERAPEUTICS INC	Director	Buy	82.5	+1,300	2.63%	✗	$1.4K
May 31, 2019	Jun 3, 2019	GALECTIN THERAPEUTICS INC	Director	Buy	86.3	+3,033	6.62%	✗	$13K
Sep 25, 2018	Sep 26, 2018	GALECTIN THERAPEUTICS INC	Director	Buy	83.8	+2,000	4.57%	✗	$12.2K